Theranostic laser system for multi-function drug activation and monitoring

Robert Perttilä; Visa Kaivosoja; Elias Kokko; Zoe Ylöniemi; Lasse Orsila; Timo Tanila; Petteri Uusimaa

doi:10.1117/12.2608726

Theranostic laser system for multi-function drug activation and monitoring

Robert Perttilä, Visa Kaivosoja, Elias Kokko, Zoe Ylöniemi, Lasse Orsila, Timo Tanila, Petteri Uusimaa

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › Scientific › peer-review

Abstract

Here we present novel cloud-connected theranostic medical laser platform specifically designed for activating and simultaneously monitoring multi-component oncological treatment processes. It may incorporate multiple wavelengths for inducing therapeutic effect or monitoring treatment in real-Time. The same low-invasive optical probers can be used for treatment and monitoring. We believe that this theranostic laser platform will allow clinicians to develop improved treatment outcomes for cancer patients that may be based on machine learning and AI in the future.

Original language	English
Title of host publication	Visualizing and Quantifying Drug Distribution in Tissue VI
Editors	Kin F. Chan, Conor L. Evans
Publisher	SPIE
ISBN (Electronic)	9781510647480
ISBN (Print)	9781510647473
DOIs	https://doi.org/10.1117/12.2608726
Publication status	Published - 2022
Publication type	A4 Article in conference proceedings
Event	Visualizing and Quantifying Drug Distribution in Tissue - San Francisco, United States Duration: 22 Jan 2022 → 27 Jan 2022

Publication series

Name	Progress in Biomedical Optics and Imaging - Proceedings of SPIE
Volume	11938
ISSN (Print)	1605-7422

Conference

Conference	Visualizing and Quantifying Drug Distribution in Tissue
Country/Territory	United States
City	San Francisco
Period	22/01/22 → 27/01/22

Keywords

Analytics
Drug delivery systems
Nanomedicine
Personalized medicine
Photoimmunotherapy
Theranostics

Publication forum classification

Publication forum level 1

ASJC Scopus subject areas

Electronic, Optical and Magnetic Materials
Atomic and Molecular Physics, and Optics
Biomaterials
Radiology Nuclear Medicine and imaging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1117/12.2608726

Cite this

Perttilä, R., Kaivosoja, V., Kokko, E., Ylöniemi, Z., Orsila, L., Tanila, T., & Uusimaa, P. (2022). Theranostic laser system for multi-function drug activation and monitoring. In K. F. Chan, & C. L. Evans (Eds.), Visualizing and Quantifying Drug Distribution in Tissue VI Article 1193804 (Progress in Biomedical Optics and Imaging - Proceedings of SPIE; Vol. 11938). SPIE. https://doi.org/10.1117/12.2608726

@inproceedings{54d6d85e221b404288bdad04d2be697f,

title = "Theranostic laser system for multi-function drug activation and monitoring",

abstract = "Here we present novel cloud-connected theranostic medical laser platform specifically designed for activating and simultaneously monitoring multi-component oncological treatment processes. It may incorporate multiple wavelengths for inducing therapeutic effect or monitoring treatment in real-Time. The same low-invasive optical probers can be used for treatment and monitoring. We believe that this theranostic laser platform will allow clinicians to develop improved treatment outcomes for cancer patients that may be based on machine learning and AI in the future.",

keywords = "Analytics, Drug delivery systems, Nanomedicine, Personalized medicine, Photoimmunotherapy, Theranostics",

author = "Robert Perttil{\"a} and Visa Kaivosoja and Elias Kokko and Zoe Yl{\"o}niemi and Lasse Orsila and Timo Tanila and Petteri Uusimaa",

note = "Publisher Copyright: {\textcopyright} COPYRIGHT SPIE. Downloading of the abstract is permitted for personal use only.; Visualizing and Quantifying Drug Distribution in Tissue ; Conference date: 22-01-2022 Through 27-01-2022",

year = "2022",

doi = "10.1117/12.2608726",

language = "English",

isbn = "9781510647473",

series = "Progress in Biomedical Optics and Imaging - Proceedings of SPIE",

publisher = "SPIE",

editor = "Chan, {Kin F.} and Evans, {Conor L.}",

booktitle = "Visualizing and Quantifying Drug Distribution in Tissue VI",

address = "United States",

}

Perttilä, R, Kaivosoja, V, Kokko, E, Ylöniemi, Z, Orsila, L, Tanila, T & Uusimaa, P 2022, Theranostic laser system for multi-function drug activation and monitoring. in KF Chan & CL Evans (eds), Visualizing and Quantifying Drug Distribution in Tissue VI., 1193804, Progress in Biomedical Optics and Imaging - Proceedings of SPIE, vol. 11938, SPIE, Visualizing and Quantifying Drug Distribution in Tissue, San Francisco, United States, 22/01/22. https://doi.org/10.1117/12.2608726

Theranostic laser system for multi-function drug activation and monitoring. / Perttilä, Robert; Kaivosoja, Visa; Kokko, Elias et al.
Visualizing and Quantifying Drug Distribution in Tissue VI. ed. / Kin F. Chan; Conor L. Evans. SPIE, 2022. 1193804 (Progress in Biomedical Optics and Imaging - Proceedings of SPIE; Vol. 11938).

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › Scientific › peer-review

TY - GEN

T1 - Theranostic laser system for multi-function drug activation and monitoring

AU - Perttilä, Robert

AU - Kaivosoja, Visa

AU - Kokko, Elias

AU - Ylöniemi, Zoe

AU - Orsila, Lasse

AU - Tanila, Timo

AU - Uusimaa, Petteri

PY - 2022

Y1 - 2022

N2 - Here we present novel cloud-connected theranostic medical laser platform specifically designed for activating and simultaneously monitoring multi-component oncological treatment processes. It may incorporate multiple wavelengths for inducing therapeutic effect or monitoring treatment in real-Time. The same low-invasive optical probers can be used for treatment and monitoring. We believe that this theranostic laser platform will allow clinicians to develop improved treatment outcomes for cancer patients that may be based on machine learning and AI in the future.

AB - Here we present novel cloud-connected theranostic medical laser platform specifically designed for activating and simultaneously monitoring multi-component oncological treatment processes. It may incorporate multiple wavelengths for inducing therapeutic effect or monitoring treatment in real-Time. The same low-invasive optical probers can be used for treatment and monitoring. We believe that this theranostic laser platform will allow clinicians to develop improved treatment outcomes for cancer patients that may be based on machine learning and AI in the future.

KW - Analytics

KW - Drug delivery systems

KW - Nanomedicine

KW - Personalized medicine

KW - Photoimmunotherapy

KW - Theranostics

U2 - 10.1117/12.2608726

DO - 10.1117/12.2608726

M3 - Conference contribution

AN - SCOPUS:85129132770

SN - 9781510647473

T3 - Progress in Biomedical Optics and Imaging - Proceedings of SPIE

BT - Visualizing and Quantifying Drug Distribution in Tissue VI

A2 - Chan, Kin F.

A2 - Evans, Conor L.

PB - SPIE

T2 - Visualizing and Quantifying Drug Distribution in Tissue

Y2 - 22 January 2022 through 27 January 2022

ER -

Theranostic laser system for multi-function drug activation and monitoring

Abstract

Publication series

Conference

Keywords

Publication forum classification

ASJC Scopus subject areas

UN SDGs

Access to Document

Fingerprint

Cite this